GenVec IncAdd to My Watchlist

GNVC:USNASDAQ CMIndustry: Medical-Biomedical/Gene
  • 2.02
  • 0.06  -2.88%
    Today's Change
  • 2.08
    Previous Close
  • Today
    52 Week Low - High
8:10 pm ET 10/2/2015
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding17 million
Market Cap$35 million
Return on Equity ttm-28.29%
Last DividendGNVC:US does not pay a dividend
EPS: Year Actual ttm-0.190
EPS: Year Est. 12/15 ttm-0.380
EPS: Quarterly Actual 6/15 -0.11
EPS: Quarterly Est. 9/15 -0.11
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate79.22
Company Description
GenVec Inc. is a clinical-stage biopharmaceutical focused on leveraging its proprietary adenovector gene delivery platform to develop a pipeline of cutting-edge therapeutics and vaccines. The Company's lead product is involved in studies involving hearing loss and balance disorders. GenVec also focuses on licensing opportunities of its proprietary vectors and production cell lines.
Revenue$6 million
Net Income$-3 million
Total Assets$16 million

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!